Еркафарм Препараты

Astellas Trains Sights On Iveric Bio In $5.9 Bi...

Astellas Pharma

Asia Business Daily on Twitter: "Astellas Pharm...

About | Astellas Pharma Ltd

Astellas Pharma to acquire Propella Therapeutic...

Astellas Pharma Joins Record Bond Sales by Japa...

Home | Astellas Pharma Canada, Inc.

Главная | Astellas Pharma Russia

Astellas Home page | Astellas Pharma Inc.

Astellas Sues Over New Myrbetriq Patent to Reca...

Astellas Pharma EMEA celebrates its 10th annive...

Japan's Astellas sees cancer drug fueling 29% p...

Astellas Pharma on LinkedIn: 医薬品の枠を超えた...

Pharmaceutical Technology

Astellas Home page | Astellas Pharma Inc.

Astellas Offloads 5 Legacy Products to Germany’...

Astellas Pharma US on LinkedIn: FDA Grants Prio...

Astellas' Prostate Cancer Drug Available In Jap...

FDA Grants Full Approval for Astellas Pharma's ...

FDA blocks Astellas’ Claudin cancer drug over m...

Astellas Pharmaceuticals Establishes Open Innov...

Astellas introduces sustainable community initi...

Атлас лекарственных растений - YouTube

China Formally Arrests Japanese Employee of Dru...

Astellas, University of Tokyo extend partnershi...

US FDA approves Astellas Pharma pill for menopa...

Главная | Astellas Pharma Russia

Astellas Pharma Projects :: Photos, videos, log...

FDA Approves Astellas’ Non-hormonal Menopause T...

Astellas Pharma - Global Web Site on Behance

Astellas

Astellas Pharma Inc. (4503N.MX) stock price, ne...

Astellas Pharma: A Contrarian Investment (OTCMK...

Astellas licenses 4DMT’s AAV vector for ophthal...

Astellas gets FDA priority review for gastric c...